iBio, Inc. (IBIO)
1.96
+0.03
(+1.55%)
USD |
NASDAQ |
Jan 02, 12:45
iBio Research and Development Expense (TTM): 10.56M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Minerva Neurosciences, Inc. | 5.569M |
| Bionano Genomics, Inc. | 11.62M |
| Vor Biopharma, Inc. | 327.69M |
| Recursion Pharmaceuticals, Inc. | 433.37M |
| Senti Biosciences, Inc. | 36.69M |